https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 09 May 2024 05:47:45 +0200Mon, 29 Apr 2024 15:35:00 +0200https://www.ema.europa.eu/en/medicines/human/EPAR/carvyktiHuman medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/carvyktiMon, 29 Apr 2024 15:35:00 +0200Human medicinehttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5095-en_1.pdfCarvykti : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5095-en_1.pdfMon, 29 Apr 2024 14:30:00 +0200Human medicinehttps://www.ema.europa.eu/en/medicines/human/variation/carvyktiSummary of opinion: Carvykti, 22/02/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/carvyktiFri, 23 Feb 2024 12:00:00 +0100Human medicine